Supernus Pharmaceuticals, Inc. (SUPN)

50.27 -1.53 (-2.95%) USD  |  NASDAQ  |  Jan 15, 16:00
50.27 0.00 (0.00%) After-Hours: 19:28
More

Supernus Pharmaceuticals EBITDA Margin Estimates for Current Quarter

EBITDA Margin Estimates for Current Quarter Chart

View EBITDA Margin Estimates for Current Quarter for SUPN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA Margin Estimates for Current Quarter Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Margin Estimates for Current Quarter Range, Past 5 Years

View EBITDA Margin Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA Margin Estimates for Current Quarter Benchmarks

View EBITDA Margin Estimates for Current Quarter Benchmarks
Start Trial
Amphastar Pharmaceuticals, Inc. Upgrade
BridgeBio Pharma, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Assembly Biosciences, Inc. Upgrade
Viking Therapeutics, Inc. --